Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 15th, there was short interest totalling 1,460,000 shares, a drop of 9.3% from the June 30th total of 1,610,000 shares. Based on an average daily volume of 386,200 shares, […]
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) General Counsel Stephen P. Ewald sold 21,850 shares of the stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $254.39, for a total value of $5,558,421.50. Following the sale, the general counsel now directly owns 14,854 shares […]
Medpace (NASDAQ:MEDP – Free Report) had its target price hoisted by Robert W. Baird from $240.00 to $260.00 in a research note issued to investors on Wednesday, FlyOnTheWall reports. Several other analysts have also commented on MEDP. StockNews.com raised Medpace from a hold rating to a buy rating in a report on Friday, May 12th. […]
Medpace (NASDAQ:MEDP – Free Report) had its price target increased by Guggenheim from $252.00 to $273.00 in a report issued on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock. A number of other analysts also recently weighed in on the stock. 22nd Century Group reissued an upgrade rating on shares […]
Medpace (NASDAQ:MEDP – Get Free Report) issued its quarterly earnings data on Monday. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03, Briefing.com reports. The business had revenue of $460.90 million during the quarter, compared to the consensus estimate of $433.75 million. Medpace had a […]